Even more concerning are the potential risks of inappropriate use. What GLP-1s Do GLP-1 medications have transformed care for people with diabetes by helping these patients improve blood sugar control, along with other cardiometabolic health benefits
Pharmaceutical companies would have to show safety, cardiometabolic benefits, adherence benefits, scalable manufacturing capabilities, and sound health economics
The obesity treatment landscape just shifted dramatically
While ibuprofen use may increase the risk of miscarriage, its important to note that miscarriage is a common experience
How FDA's Action Against Non-FDA-Approved GLP-1 Products Affects the Competitive Landscape Nicholas Jacobus , Jay Bregman Jay Bregman, CEO and co-founder of Andel discusses how FDAs planned action against non-FDA-approved GLP-1 products could reshape competition in obesity and diabetes care